Indication
Maintenance therapy for asthma
Asthma is a chronic inflammatory disorder of the conducting airways that affects pediatric and adult populations worldwide. Read more about Maintenance therapy for asthma
168 drugs 75 manufacturers
Drugs that treat it
Common Maintenance therapy for asthma therapies.
ZAFIRLUKAST
ZILEUTON ER (zileuton)
MONTELUKAST SODIUM
ZAFIRLUKAST
BUDESONIDE
MONTELUKAST SODIUM
ADVAIR DISKUS (fluticasone propionate/salmeterol xinafoate)
BUDESONIDE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAsthma is a chronic inflammatory disorder of the conducting airways that affects pediatric and adult populations worldwide.
It is clinically characterized by recurrent, variable respiratory symptoms—such as wheezing, dyspnea, chest tightness, and cough—accompanied by widespread, often reversible expiratory airflow limitation and bronchial hyperresponsiveness.
In this context, maintenance therapy is indicated for long-term disease control in patients with persistent asthma to suppress underlying airway inflammation, preserve baseline pulmonary function, minimize daytime and nocturnal impairment, and mitigate the risk of severe exacerbations.
- nih.gov
Asthma is a chronic inflammatory disorder of the conducting airways that affects pediatric and adult populations worldwide
- nih.gov
Asthma is a chronic inflammatory disorder of the conducting airways that affects pediatric and adult populations worldwide
- aafp.org
Asthma is a chronic inflammatory disorder of the conducting airways that affects pediatric and adult populations worldwide
- ginasthma.org
It is clinically characterized by recurrent, variable respiratory symptoms—such as wheezing, dyspnea, chest tightness, and cough—accompanied by widespread, often reversible expiratory airflow limitation and bronchial hyperresponsiveness
- nih.gov
It is clinically characterized by recurrent, variable respiratory symptoms—such as wheezing, dyspnea, chest tightness, and cough—accompanied by widespread, often reversible expiratory airflow limitation and bronchial hyperresponsiveness In this context, maintenance therapy is indicated for long-term disease control in patients with persistent asthma to suppress underlying airway inflammation, preserve baseline pulmonary function, minimize daytime and nocturnal impairment, and mitigate the risk o...
- 2minutemedicine.com
It is clinically characterized by recurrent, variable respiratory symptoms—such as wheezing, dyspnea, chest tightness, and cough—accompanied by widespread, often reversible expiratory airflow limitation and bronchial hyperresponsiveness
- nih.gov
In this context, maintenance therapy is indicated for long-term disease control in patients with persistent asthma to suppress underlying airway inflammation, preserve baseline pulmonary function, minimize daytime and nocturnal impairment, and mitigate the risk of severe exacerbations
- nih.gov
In this context, maintenance therapy is indicated for long-term disease control in patients with persistent asthma to suppress underlying airway inflammation, preserve baseline pulmonary function, minimize daytime and nocturnal impairment, and mitigate the risk of severe exacerbations
Personalize your experience
Follow Maintenance therapy for asthma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.